Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access                       
ValueForum.com Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain SCLN message board posts where the ticker symbol SCLN has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

• Latest SCLN SEC Filings

Filings Format Description Filed/Effective File/Film Number
EFFECT  Documents Notice of Effectiveness
Acc-no: 9999999995-17-002874 (33 Act)  Size: 1 KB
2017-11-06 333-30938
171180972
EFFECT  Documents Notice of Effectiveness
Acc-no: 9999999995-17-002880 (33 Act)  Size: 1 KB
2017-11-06 333-84487
171180971
EFFECT  Documents Notice of Effectiveness
Acc-no: 9999999995-17-002875 (33 Act)  Size: 1 KB
2017-11-06 333-52471
171180965
EFFECT  Documents Notice of Effectiveness
Acc-no: 9999999995-17-002881 (33 Act)  Size: 1 KB
2017-11-06 333-85673
171180970
EFFECT  Documents Notice of Effectiveness
Acc-no: 9999999995-17-002876 (33 Act)  Size: 1 KB
2017-11-06 333-62309
171180964
EFFECT  Documents Notice of Effectiveness
Acc-no: 9999999995-17-002878 (33 Act)  Size: 1 KB
2017-11-06 333-77543
171180969
EFFECT  Documents Notice of Effectiveness
Acc-no: 9999999995-17-002879 (33 Act)  Size: 1 KB
2017-11-06 333-81481
171180968
EFFECT  Documents Notice of Effectiveness
Acc-no: 9999999995-17-002877 (33 Act)  Size: 1 KB
2017-11-06 333-72800
171180966
EFFECT  Documents Notice of Effectiveness
Acc-no: 9999999995-17-002865 (33 Act)  Size: 1 KB
2017-11-06 333-216565
171180951
EFFECT  Documents Notice of Effectiveness
Acc-no: 9999999995-17-002863 (33 Act)  Size: 1 KB
2017-11-06 333-176209
171180953
More SCLN SEC Filings


Related news from
Fri, 13 Oct 2017
22:22:11 +0000
[$$] Investor Group Buys SciClone Pharmaceuticals
SciClone Pharmaceuticals, a Foster City, Calif.-based drug company focused on China, was acquired by an investor consortium led by GL Capital.
Fri, 13 Oct 2017
20:24:00 +0000
Consortium Led By GL Capital Completes Acquisition Of SciClone
FOSTER CITY, Calif., Oct. 13, 2017 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (SCLN) (the "Company" or "SciClone") and a consortium consisting of entities affiliated with GL Capital Management GP Limited ("GL Capital"), Bank of China Group Investment Limited ("BOCGI"), CDH Investments, Ascendent Capital Partners and Boying (collectively, the "Buyer Consortium") today announced completion of the merger contemplated by the previously announced agreement and plan of merger (the "Merger Agreement), dated June 7, 2017, by and between Silver Biotech Investment Limited ("Holdco"), Silver Delaware Investment Limited ("Merger Sub") and the Company. As a result of the merger, the Company ceased to be a publicly traded company on the NASDAQ Global Select Market ("NASDAQ") and became a subsidiary of Holdco.
Wed, 11 Oct 2017
22:07:00 +0000
NMI Holdings and Axcelis Technologies Set to Join S&P SmallCap 600
NEW YORK , Oct. 11, 2017 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes in the S&P SmallCap 600: NMI Holdings Inc. (NASD: NMIH) will replace SciClone Pharmaceuticals Inc. (NASD: ...
Wed, 11 Oct 2017
12:23:03 +0000
SciClone Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : SCLN-US : October 11, 2017
Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for SciClone Pharmaceuticals, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish ... Read more <b>(Read more...)</b>
Mon, 09 Oct 2017
16:00:54 +0000
ETFs with exposure to SciClone Pharmaceuticals, Inc. : October 9, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to SciClone Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to SCLN-US. Comparing the performance and risk of SciClone Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more <b>(Read more...)</b>
Thu, 28 Sep 2017
14:19:24 +0000
ETFs with exposure to SciClone Pharmaceuticals, Inc. : September 28, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to SciClone Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to SCLN-US. Comparing the performance and risk of SciClone Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more <b>(Read more...)</b>
Wed, 27 Sep 2017
13:04:33 +0000
SciClone Pharmaceuticals, Inc. :SCLN-US: Earnings Analysis: Q2, 2017 By the Numbers : September 27, 2017
Categories: Yahoo FinanceGet free summary analysis SciClone Pharmaceuticals, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of SciClone Pharmaceuticals, Inc. – Intercept Pharmaceuticals, Inc., Enanta Pharmaceuticals, Inc., Hemispherx Biopharma, Inc. and Pfizer Inc. (ICPT-US, ENTA-US, HEB-US and PFE-US) that have also reported for this period. ... Read more <b>(Read more...)</b>
Fri, 15 Sep 2017
01:22:11 +0000
SciClone Pharmaceuticals, Inc. – Value Analysis (NASDAQ:SCLN) : September 15, 2017
Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives SciClone Pharmaceuticals, Inc. a score of 69. Our analysis is based on comparing SciClone Pharmaceuticals, Inc. with the following peers – Enzon Pharmaceuticals, Inc., Intercept Pharmaceuticals, Inc., Enanta Pharmaceuticals, Inc., SEI Investments Company, Vertex Pharmaceuticals Incorporated, Baxter International Inc., Hemispherx Biopharma, Inc., Pfizer Inc., Bristol-Myers Squibb Company ... Read more <b>(Read more...)</b>
Wed, 13 Sep 2017
13:40:55 +0000
SciClone Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : SCLN-US : September 13, 2017
Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for SciClone Pharmaceuticals, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish ... Read more <b>(Read more...)</b>
Tue, 29 Aug 2017
18:00:00 +0000
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of SciClone Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 30, 2017
Levi & Korsinsky, LLP has filed a class action lawsuit in the United States District Court for the Northern District of California on behalf of current stockholders of SciClone Pharmaceuticals, Inc.
Tue, 29 Aug 2017
11:30:00 +0000
Corporate News Blog - Novo Nordisk’s Victoza(R) Receives Approval from FDA
Research Desk Line-up: SciClone Pharma Post Earnings Coverage LONDON, UK / ACCESSWIRE / August 29, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for ...
Thu, 10 Aug 2017
20:05:00 +0000
SciClone Announces End Of Go-Shop Period With No Parties Designated As Excluded Parties
Under the terms of the Merger Agreement, the Company and its advisors were permitted to actively solicit and negotiate alternative acquisition proposals from third parties during a "go-shop" period.  During the "go-shop" period, representatives of Lazard Frères & Co. LLC ("Lazard"), financial advisor to the Company, under took a broad solicitation effort, contacting 38 potential acquirers, including 28 strategic parties and 10 financial parties that the Company and Lazard believed might be interested in a possible alternative transaction to the merger with the Buyer Consortium. As a result of these efforts, Company received one alternative acquisition proposal.
Wed, 09 Aug 2017
21:30:59 +0000
SciClone posts 2Q profit
On a per-share basis, the Foster City, California-based company said it had net income of 23 cents. Earnings, adjusted for stock option expense and non-recurring costs, came to 30 cents per share. The ...
Wed, 09 Aug 2017
20:05:00 +0000
SciClone Reports Second Quarter 2017 Financial Results
FOSTER CITY, Calif. , Aug. 9, 2017 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today reported financial results for the quarter ended June 30, 2017 . Revenues: In the second quarter of ...
Fri, 04 Aug 2017
01:23:25 +0000
ETFs with exposure to SciClone Pharmaceuticals, Inc. : August 4, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to SciClone Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to SCLN-US. Comparing the performance and risk of SciClone Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more <b>(Read more...)</b>
Mon, 03 Jul 2017
19:55:00 +0000
Lifshitz&Miller LLP Announces Investigation of ARI Network Services, Inc., DuPont Fabros Technology, Inc., Nexvet Biopharma Public Limited Company, PAREXEL International Corporation, Rice Energy Inc. and SciClone Pharmaceuticals, Inc.
NEW YORK , July 3, 2017 /PRNewswire/ -- ARI Network Services, Inc. (ARIS) Lifshitz & Miller announces investigation into possible breaches of fiduciary duties by the board in connection with the proposed ...
Mon, 19 Jun 2017
20:04:58 +0000
ETFs with exposure to SciClone Pharmaceuticals, Inc. : June 19, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to SciClone Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to SCLN-US. Comparing the performance and risk of SciClone Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more <b>(Read more...)</b>
Mon, 19 Jun 2017
19:18:00 +0000
INVESTOR ALERT: Brower Piven Commences an Investigation into the Proposed Sale of SciClone Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm for Additional Information
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of SciClone Pharmaceuticals, Inc.
Mon, 19 Jun 2017
18:55:00 +0000
SCICLONE INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of SciClone Pharmaceuticals, Inc.
NEW ORLEANS , June 19, 2017 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sale ...
Fri, 16 Jun 2017
16:22:02 +0000
SciClone Pharmaceuticals, Inc. :SCLN-US: Earnings Analysis: Q1, 2017 By the Numbers : June 16, 2017
Categories: Yahoo FinanceGet free summary analysis SciClone Pharmaceuticals, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of SciClone Pharmaceuticals, Inc. – Enzon Pharmaceuticals, Inc., Intercept Pharmaceuticals, Inc., Enanta Pharmaceuticals, Inc., SEI Investments Company, Vertex Pharmaceuticals Incorporated, Baxter International Inc., Hemispherx Biopharma, Inc., Pfizer Inc., Bristol-Myers ... Read more <b>(Read more...)</b>



"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "No friend, no book, no broker, no advisor, no expert has ever provided a tenth what I am able to find here. The best money I have EVER spent, is for membership." more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
 
Nothing in ValueForum.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ValueForum.com. ©2003 - 2017, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards